Product Information
JATENZO 158 MG CAPSULE is a brand product labeled by TOLMAR Inc., priced at $8.9583 per EA under NDC 69087015812. Its NADAC has been published 110 times since May 22, 2024.
Strength
158 mg/1
Manufacturer
TOLMAR Inc.NDC
69087015812
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TESTOSTERONE UNDECANOATEApproval Type
New Drug (NDA)
FDA Application
NDA206089On Market Since
8/1/2019
Pharmacological Classes
Price Statistics
The NADAC for JATENZO 158 MG CAPSULE has been published 110 times since May 22, 2024, and over the history we have for it it has risen 8.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9583 per EA |
|---|---|
| All-time high | $8.9803 (May 13, 2026) |
| All-time low | $8.2534 (May 22, 2024) |
| 52-week high | $8.9803 |
| 52-week low | $8.6274 |
| Median price | $8.6274 |
| Average price | $8.6073 |
| Largest weekly change | +4.0% (Jan 7, 2026) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the testosterone undecanoate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of JATENZO 158 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for JATENZO 158 MG CAPSULE, manufactured by TOLMAR Inc., is $8.9583 per EA (NDC 69087015812), effective Jun 24, 2026.
How has the price of JATENZO 158 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for JATENZO 158 MG CAPSULE has risen 8.5%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for JATENZO 158 MG CAPSULE?
Since May 22, 2024, the NADAC for JATENZO 158 MG CAPSULE has ranged from a low of $8.2534 (May 22, 2024) to a high of $8.9803 (May 13, 2026), with a median of $8.6274 per EA.
Are there cheaper alternatives to JATENZO 158 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of JATENZO 158 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures JATENZO 158 MG CAPSULE?
JATENZO 158 MG CAPSULE (NDC 69087015812) is labeled by TOLMAR Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification